Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

Item

http://www.wikidata.org/entity/Q40470351

Q40470351

about

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia Extended-spectrum beta-lactamases: a clinical update Updated functional classification of beta-lactamases Early detection of pneumonia as a risk factor for mortality in burn patients in Menoufiya University Hospitals, Egypt Automated image analysis for quantification of filamentous bacteria Bacterial temporal dynamics enable optimal design of antibiotic treatment Crowdsourced Data Indicate Widespread Multidrug Resistance in Skin Flora of Healthy Young Adults.Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.Extended-spectrum β-lactamases in Gram Negative Bacteria.The inoculum effect of antibiotics against CTX-M-extended-spectrum β-lactamase-producing Escherichia coli.Evaluation of inhibitory action of novel non β-lactam inhibitor against Klebsiella pneumoniae carbapenemase (KPC-2)Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria Confronting bacterial resistance in healthcare settings: a crucial role for microbiologists.Resistance to antimicrobial agents: an update.Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns.Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience.Healthcare-associated pneumonia: principles and emerging concepts on management.Cefepime: a reappraisal in an era of increasing antimicrobial resistance.Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results Functional relationship between bacterial cell density and the efficacy of antibiotics.Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?Evaluation of the relationship between the minimum inhibitory concentration of ceftiofur and third-generation cephalosporins in Escherichia coli isolates from food-producing animals.The rapid detection of cefotaxime-resistant Enterobacteriaceae by HPLC.Emergence of blaCTX-M-15, blaTEM-169 and blaPER-1 extended-spectrum β-lactamase genes among different Salmonella enterica serovars from human faecal samples.Fitness trade-offs in blaTEM evolution.The Poisoned Well: Enhancing the Predictive Value of Antimicrobial Susceptibility Testing in the Era of Multidrug Resistance.Cefepime monotherapy for treatment of febrile neutropenia in children.Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli.Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China Occurrence of Plasmid-Mediated AmpC β-Lactamases Among Escherichia coli and Klebsiella pneumoniae Clinical Isolates in a Tertiary Care Hospital in Bangalore.Agar dilution method for detection of inducible clindamycin resistance in Staphylococcus spp.Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria.Report from the Task Force on Zoonoses Data Collection including guidance for harmonized monitoring and reporting of antimicrobial resistance in commensal Escherichia coli and Enterococcus spp. from food animals Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology.Isolation of ESBL-producing Bacteria from Sputum in Community-acquired Pneumonia or Healthcare-associated Pneumonia Does Not Indicate the Need for Antibiotics with Activity against This Class.

P2860

Q22241905-3833A4BB-E914-4BB6-963C-4673B2CF7B2F Q24534999-878DACE0-3D3E-4502-B71E-F1699782EF73 Q24644798-0D8CADD9-F3CF-490E-B7EA-F242944C7316 Q26999305-CDB74136-DEEB-4A18-B127-D990111552C2 Q27316219-2A1FA417-D543-4F58-9DDF-BAD25C1D6034 Q28546654-2B171969-AD6A-4D59-92F3-09077F1F8BBF Q30386797-F4F8E9D8-2703-4749-969B-CA7824E9A40C Q33613797-DF283648-C829-4256-86AE-5E8D611D6F41 Q34159849-8CFC7F6C-FCA2-4D65-AE5A-B279238204B0 Q35158603-BD4F1EC2-6684-46EE-BB4C-F7518A0B2FF3 Q35284418-5B9C3F98-7292-4178-BDFD-CA48F8EA252E Q35356144-20C59A1A-538E-40D2-9F65-7D19EC3E7BCD Q35600060-B62B13C7-3439-4631-9014-0D932E7D3EFB Q35745242-4E7B779A-57C0-4215-9F00-F01F2F19A373 Q35976850-A7CB94E2-0637-4E2A-9D28-E3572CCEEB8A Q36105222-0CF31BAA-FCAE-4B2B-9AEF-0510E5B835FD Q36424079-DD35BC64-E47B-469E-8746-47ACF2147BD0 Q36949536-FC6274A3-8150-4ECE-A936-3C2258C52A11 Q37013020-99C406B5-AF44-4B19-B63B-4DD21F2F8474 Q37079350-1505FDF7-98F6-4063-A707-7F81DD182E62 Q37099549-E4FB8F01-9E8B-450B-94E4-87E9D6955734 Q37124158-4E25FC70-D3F3-44D1-823B-DFBA12045DC6 Q37998436-AC14111C-94E4-471E-86C8-DA050D007EB6 Q38671171-F3520AB4-E376-417A-8F5A-4DC4F494A86D Q38766625-F9DE70F6-0823-4323-ABA9-9D48A407C864 Q38875423-C01BA0E0-8D0C-4703-9806-41DA98D06799 Q39687225-1D457E1A-5CCD-43A5-99C7-34DD51B424BC Q40227755-B65089AB-2C8E-4FD3-9BF5-542CA61460F6 Q40465101-A5B2D614-6379-4B1C-84F5-57A6C5EF758C Q41870270-54A50B1C-9CD0-4AED-8BA2-16427E2C5C1D Q41995038-9BAAF841-6449-41E0-8FDF-B4636D6079A6 Q42201691-A5AC14DB-2992-4A8D-8E0B-DF79AE6AB082 Q42910041-EF0BF683-E8EE-47E4-B65E-137A5E6B6AA6 Q42929547-9A469360-154F-463B-A459-30549C5B7184 Q43144149-150BF9EE-FF71-47AF-986B-422C95F639E7 Q43227341-8C1E4F06-916F-4100-8745-06846B233273 Q43865391-F27D6403-9514-4467-A23F-19964D9FCA88 Q47145339-BE2E2E96-0F6B-46FC-A909-E2692B95F31E Q47677580-82BD957B-BE5F-47C4-9A56-2D18815A794C Q47747140-418FEDFF-2180-42DE-B8CD-56B86703278B

P2860

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

Item

http://www.wikidata.org/entity/Q40470351

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Effects of inoculum and beta-l ...... y using NCCLS ESBL methodology

@en

type

Item

label

Effects of inoculum and beta-l ...... y using NCCLS ESBL methodology

@en

prefLabel

Effects of inoculum and beta-l ...... y using NCCLS ESBL methodology

@en

P1476

Effects of inoculum and beta-l ...... y using NCCLS ESBL methodology

@en

P2093

Anne Marie Queenan

http://www.w3.org/2001/XMLSchema#string

Barbara Foleno

http://www.w3.org/2001/XMLSchema#string

Colleen Gownley

http://www.w3.org/2001/XMLSchema#string

Ellyn Wira

http://www.w3.org/2001/XMLSchema#string

Karen Bush

http://www.w3.org/2001/XMLSchema#string

P2860

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

A functional classification scheme for beta-lactamases and its correlation with molecular structure

Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri

Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18

In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.

Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate.

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.

P304

269-275

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.42.1.269-275.2004

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14715764

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

Escherichia coli

P932

321709

http://www.w3.org/2001/XMLSchema#string

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

about

P2860

P2860

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932